Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Operating Expenses | 5,298 | 4,868 | 2,803 | 2,110 | 2,260 |
| Operating Income | -5,298 | -4,868 | -2,803 | -2,110 | -2,260 |
| Other Income | 0 | 1 | 5 | 0 | 0 |
| Pre-tax Income | -5,298 | -4,867 | -2,798 | -2,110 | -2,260 |
| Net Income Continuous | -5,298 | -4,867 | -2,798 | -2,110 | -2,260 |
| Net Income | $-5,298 | $-4,867 | $-2,798 | $-2,110 | $-2,260 |
| EPS Basic Total Ops | -0.14 | -0.17 | -0.11 | -0.09 | -0.11 |
| EPS Basic Continuous Ops | -0.14 | -0.18 | -0.11 | -0.09 | -0.11 |
| EPS Diluted Total Ops | -0.14 | -0.17 | -0.11 | -0.09 | -0.11 |
| EPS Diluted Continuous Ops | -0.14 | -0.18 | -0.11 | -0.09 | -0.11 |
| EBITDA(a) | $-5,113 | $-4,803 | $-2,798 | $-2,109 | $-2,243 |